Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

Tenaya Therapeutics, Inc. (TNYA)

NASDAQ

$0.63

$-0.03

(-5.04%)

Tenaya Therapeutics, Inc. (TNYA) Live Price Chart

Page last updated: 2026-03-30 18:54:00

Key Market Data

Market Cap	$136.71M
Open	$0.68
High	$32.00
Low	$0.36
Previous Close	$0.67
Price Change	$-0.03
Percentage Change	-5.04%
Volume	2M

Tenaya Therapeutics, Inc. (TNYA) Stock Price Today

Tenaya Therapeutics, Inc. (TNYA) is currently trading at $0.63 as of 2026-03-30 18:54:00, reflecting a -5.04% move ($-0.03) from the previous close.

In the short term, the stock has returned +10.53% over the past four weeks. Over the last 12 months, Tenaya Therapeutics, Inc. has recorded a +10.51% price change, indicating a stable performance relative to the broader market.

Tenaya Therapeutics, Inc. (TNYA) 7-Day Stock Price Changes

Over the past seven days, Tenaya Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $0.74 to the latest recorded price of $0.63, reflecting an intraday change of -5.04%. Daily movements highlight shifts in trading volume (2,082,712), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TNYA has delivered a +10.53% return over the past month and a +10.51% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy Tenaya Therapeutics, Inc. (TNYA)

You can buy and trade TNYA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TNYA and Execute Your Trade

Open the trading page, enter TNYA in the search bar, select the amount of TNYA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Tenaya Therapeutics, Inc. (TNYA)?

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Tenaya Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	70
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.tenayatherapeutics.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Tenaya Therapeutics, Inc.?

The latest trading price for Tenaya Therapeutics, Inc. (Common Stock) is $ 0.63, compared with a previous closing price of $ 0.67. That means the stock has moved -5.04% so far today. Intraday price updates and recent trading activity for TNYA can be tracked on the live chart and quote section on this page.

2.Is Tenaya Therapeutics, Inc. stock going up or down?

Looking at recent performances, TNYA has returned +10.53% over the past month, -60.63% over the last six months and +10.51% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Tenaya Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does TNYA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Tenaya Therapeutics, Inc. has traded between a low of $ 0.36 and a high of $ 2.35. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether TNYA is currently nearer the top or the bottom of its one-year trading band.

4.How is Tenaya Therapeutics, Inc. classified by sector and industry?

Tenaya Therapeutics, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Tenaya Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing TNYA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Tenaya Therapeutics, Inc.’s performance.

5.Where is Tenaya Therapeutics, Inc. listed and how large is it by market value?

Tenaya Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 136.71M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Tenaya Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does TNYA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.42 summarises how much profit Tenaya Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Tenaya Therapeutics, Inc.'s financial performance over time?

To follow Tenaya Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TNYA is performing and how the market is responding.

8.When is Tenaya Therapeutics, Inc. expected to report earnings?

Tenaya Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TNYA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Tenaya Therapeutics, Inc.'s earnings reports?

Tenaya Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TNYA is meeting, beating or missing expectations.

10.How can I stay informed about Tenaya Therapeutics, Inc.'s results and guidance?

You can stay up to date on Tenaya Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TNYA on this page helps you see how new information is being reflected in the stock.

11.Does Tenaya Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Tenaya Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TNYA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TNYA?

Based on the latest earnings data, TNYA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Tenaya Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Tenaya Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Tenaya Therapeutics, Inc.?

Tenaya Therapeutics, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TNYA valued in terms of P/E ratio and EPS?

Tenaya Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.42. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Tenaya Therapeutics, Inc.'s earnings. Comparing TNYA's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Tenaya Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Endeavour Silver Corp.

EXK

First Foundation Inc.

FFWM

Medifast, Inc.

MED

The Magnum Ice Cream Company N.V.

MICC

Movado Group, Inc.

MOV

Top Gainers

Browse today's leading gainers in the US stock market

Astrotech Corporation (DE)

ASTC

Bullfrog AI Holdings, Inc.

BFRG

Creative Media & Community Trust Corporation

CMCT

PMGC Holdings Inc.

ELAB

Greenland Energy Company

GLND

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

TNYA-to-USD Calculator

Amount

TNYA

USD

1 TNYA = 0.63 USD